296 results on '"Baba, Yuichi"'
Search Results
2. Cardiac sarcoidosis treated with nonsteroidal immunosuppressive therapy
3. Association Between Right Bundle Branch Block and Ventricular Arrhythmia in Patients With Cardiac Sarcoidosis
4. Associations between electrocardiographic findings and echocardiographic profiles in patients with hypertrophic cardiomyopathy
5. The role of ferroptosis in cell-to-cell propagation of cell death initiated from focal injury in cardiomyocytes
6. A retrospective investigation to establish new screening approach for the detection of patients at high risk of Fabry disease in male left ventricular hypertrophy patients
7. Validation of the Kumamoto criteria for prediction of 99m technetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: A retrospective cohort study in Kochi
8. Importance of fourth heart sound and preserved left atrial function in wild‐type transthyretin amyloidosis.
9. Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type I
10. Clinical and Prognostic Values of ALBI Score in Patients With Acute Heart Failure
11. Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and 99mTc-pyrophosphate scintigraphy
12. The diaphragm affects echocardiographic measurement of inferior vena cava diameter to predict right atrial pressure
13. Reconsideration of the cut-off value of angiotensin-converting enzyme for screening of sarcoidosis in Japanese patients
14. The effects of Tel2 on cardiomyocyte survival
15. Characteristics and incidence of cardiac events across spectrum of age in cardiac sarcoidosis
16. Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE‐CS study
17. Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy
18. Prevalence and Prognostic Value of Atrial Fibrillation in Patients with Cardiac Sarcoidosis
19. The role of ferroptosis in cell-to-cell propagation of cell deathinitiated from focal injury in cardiomyocytes
20. Associations between electrocardiographic findings and echocardiographic profiles in patients with hypertrophic cardiomyopathy
21. Where Is the Left Atrial Appendage Wall? Caution during Transesophageal Echocardiography
22. Erythrocyte creatine as a marker of intravascular hemolysis due to left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
23. Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE‐CS study.
24. Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis
25. Gender differences in the clinical features of hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations
26. The mTOR Signaling Pathway in Myocardial Dysfunction in Type 2 Diabetes Mellitus
27. Dove-Coo Murmur From Pulmonary Regurgitation Is Associated With Tiger Stripes Sign
28. Prognostic Implication of the Resolution of Myocardial FDG Uptake in Patients With Cardiac Sarcoidosis
29. REDUCTION OF ABNORMAL FDG UPTAKE ON PET/CT IS A PREDICTOR OF ALL-CAUSE MORTALITY IN PATIENTS WITH CARDIAC SARCOIDOSIS
30. Relationship of mild to moderate impairment of left ventricular ejection fraction with fatal ventricular arrhythmic events in cardiac sarcoidosis
31. High-sensitivity Cardiac Troponin T is a Useful Biomarker for Predicting the Prognosis of Patients with Systemic Sarcoidosis Regardless of Cardiac Involvement
32. The Prognostic Value of B‐Type Natriuretic Peptide in Patients With Cardiac Sarcoidosis Without Heart Failure: Insights From ILLUMINATE‐CS
33. Clinical Features of Heart Failure in Patients With Hypertrophic Cardiomyopathy in a Regional Japanese Cohort ― Results From the Kochi RYOMA Study ―
34. Abstract 16192: Protective Effects of the Mechanistic Target of Rapamycin Against Excess Iron and Ferroptosis in Cardiomyocytes
35. N‐terminal pro‐brain natriuretic peptide is a useful marker to identify latent heart failure patients in older adults in a rural outpatient clinic
36. A Drifting Dislodged Leadless Pacemaker in the Bilateral Pulmonary Arteries
37. Serum tenascin-C levels as a prognostic biomarker of heart failure events in patients with hypertrophic cardiomyopathy
38. Comparisons between biopsy-proven versus clinically diagnosed cardiac sarcoidosis
39. Plasma metalloproteinase levels and left ventricular remodeling in hypertrophic cardiomyopathy in patients with an identical mutation
40. Tissue Doppler Imaging and Plasma BNP Levels to Assess the Prognosis in Patients with Hypertrophic Cardiomyopathy
41. Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry
42. Very long‐term prognosis in patients with hypertrophic cardiomyopathy: a longitudinal study with a period of 20 years
43. Early Experience of Tafamidis Treatment in Japanese Patients With Wild-Type Transthyretin Cardiac Amyloidosis From the Kochi Amyloidosis Cohort
44. Glucuronyltransferase Activity of KfiC from Escherichia coli Strain K5 Requires Association of KfiA: KfiC AND KfiA ARE ESSENTIAL ENZYMES FOR PRODUCTION OF K5 POLYSACCHARIDE, N-ACETYLHEPAROSAN
45. A novel cardiac myosin-binding protein C S297X mutation in hypertrophic cardiomyopathy
46. Diagnostic and Therapeutic Strategy for Female Patients With Cardiac Amyloidosis ― Reply ―
47. The High Road or the Low Road? A Question Regarding Whether to Use Upper or Lower Pulmonary Veins in Measuring Pulmonary Vein Flow
48. Inferior acute myocardial infarction due to acute cardiac herniation after right pneumonectomy
49. Clinical significance of new‐onset atrial fibrillation in patients with hypertrophic cardiomyopathy
50. Wild-Type Transthyretin Amyloidosis in Female Patients ― Consideration of Sex Differences ―
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.